Abstract: A curable composition apportioned between at least one Part A and at least one Part B, the Parts sealed within barrier means preventing contamination, the at least one Part A comprising: (i) one or more alkenyl-group containing prepolymers having at least one alkenyl group or moiety per molecule, and the at least one Part B comprising: (ii) one or more SiH-containing prepolymers having at least one Si—H unit per molecule; the composition additionally comprising: (iii) a catalyst for curing by addition of alkenyl-containing prepolymer (i) to SiH-containing prepolymer (ii), wherein prepolymer (ii) is substantially absent from Part A and prepolymer (i) is substantially absent from Part B, methods for preparing the composition, methods for sterilisation thereof, medical and non-medical use thereof, a device incorporating the composition, and a precursor therefor including its sterilisable precursor composition, in particular a terminally sterilisable or terminally sterile composition for medical use, particularl

Abstract: A curable composition apportioned between at least one Part A and at least one Part B, the Parts sealed within barrier means preventing contamination, the at least one Part A comprising: (i) one or more alkenyl-group containing prepolymers having at least one alkenyl group or moiety per molecule, and the at least one Part B comprising: (ii) one or more SiH-containing prepolymers having at least one Si—H unit per molecule; the composition additionally comprising: (iii) a catalyst for curing by addition of alkenyl-containing prepolymer (i) to SiH-containing prepolymer (ii), wherein prepolymer (ii) is substantially absent from Part A and prepolymer (i) is substantially absent from Part B, methods for preparing the composition, methods for sterilisation thereof, medical and non-medical use thereof, a device incorporating the composition, and a precursor therefor including its sterilisable precursor composition, in particular a terminally sterilisable or terminally sterile composition for medical use, particularl

Abstract: A curable composition apportioned between at least one Part A and at least one Part B, the Parts sealed within barrier means preventing contamination, the at least one Part A comprising: (i) one or more alkenyl-group containing prepolymers having at least one alkenyl group or moiety per molecule, and the at least one Part B comprising: (ii) one or more SiH-containing prepolymers having at least one Si—H unit per molecule; the composition additionally comprising: (iii) a catalyst for curing by addition of alkenyl-containing prepolymer (i) to SiH-containing prepolymer (ii), wherein prepolymer (ii) is substantially absent from Part A and prepolymer (i) is substantially absent from Part B, methods for preparing the composition, methods for sterilisation thereof, medical and non-medical use thereof, a device incorporating the composition, and a precursor therefor including its sterilisable precursor composition, in particular a terminally sterilisable or terminally sterile composition for medical use, particularly

Abstract: A curable composition apportioned between at least one Part A and at least one Part B, the Parts sealed within barrier means preventing contamination, the at least one Part A comprising: (i) one or more alkenyl-group containing prepolymers having at least one alkenyl group or moiety per molecule, and the at least one Part B comprising: (ii) one or more SiH-containing prepolymers having at least one Si—H unit per molecule; the composition additionally comprising: (iii) a catalyst for curing by addition of alkenyl-containing prepolymer (i) to SiH-containing prepolymer (ii), wherein prepolymer (ii) is substantially absent from Part A and prepolymer (i) is substantially absent from Part B, methods for preparing the composition, methods for sterilisation thereof, medical and non-medical use thereof, a device incorporating the composition, and a precursor therefor including its sterilisable precursor composition, in particular a terminally sterilisable or terminally sterile composition for medical use, particularly

Abstract: An article having antifouling properties and intended to be employed in aquatic uses, in particular marine uses. In particular there is provided an article having antifouling properties and intended to be employed in aquatic uses which comprises: a) a support, b) optionally, at least one primer coat on said support comprising at least one anticorrosive product, c) optionally, at least one intermediate primer coat promoting adhesion between the coats, d) at least one adhesion-promoting coat or tie coat, deposited on said primer coat or on said support when the primer coat is absent, and e) at least one antifouling coat or topcoat, deposited on said adhesion-promoting coat or tie coat.

Abstract: An article having antifouling properties and intended to be employed in aquatic uses, in particular marine uses, which comprises: a) a support, b) optionally, at least one primer coat on said support comprising at least one anticorrosive product, c) optionally, at least one intermediate primer coat promoting adhesion between the coats, d) at least one adhesion-promoting coat or tie coat, deposited on said primer coat or on said support when the primer coat is absent, and e) at least one antifouling coat or topcoat, deposited on said adhesion-promoting coat or tie coat.

Abstract: A composition comprising: at least one organosilicon compound A comprising at least two identical or different hydrolyzable and condensable groups, or at least two silanol functions ?SiOH, at least one crosslinking agent B, optionally at least one filler C, and a catalytically effective amount of at least one polycondensation catalyst M which is a zinc complex comprising in its structure a first type of ligand that is a ?-diketonate and a second type of ligand that is an amine.

Abstract: The invention relates to an article with antifouling properties, intended for aquatic uses and, in particular, for marine uses, and to a method for slowing down the growth of aquatic organisms on submersible or semi-subermisible structures.

Abstract: The invention relates to an article with antifouling properties, intended for aquatic uses and, in particular, for marine uses, and to a method for slowing down the growth of aquatic organisms on submersible or semi-submersible structures.

Abstract: The present invention relates to an organopolysiloxane composition which is suitable for vulcanization into an elastomer as from room temperature, and which crosslinks via polycondensation, as well as to new organopolysiloxane polycondensation catalysts.

Abstract: The present invention relates to an organopolysiloxane composition which is suitable for vulcanisation into an elastomer as from room temperature, and which crosslinks via polycondensation, as well as to new organopolysiloxane polycondensation catalysts.

Abstract: The invention relates to an article with antifouling properties, intended for aquatic uses and, in particular, for marine uses, and to a method for slowing down the growth of aquatic organisms on submersible or semi-submersible structures.

Abstract: The invention relates to an article with antifouling properties, intended for aquatic uses and, in particular, for marine uses, and to a method for slowing down the growth of aquatic organisms on submersible or semi-subermisible structures.

Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to several novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

Abstract: The present relates to novel organopolysiloxane compositions intended to generate an elastomer foam (or silicone foam) with good mechanical properties and low density low density, i.e. less than 0.35 g/cm3 and preferably less than 0.25 g/cm3.

Abstract: RTV-organopolysiloxane compositions are crosslinkable by polycondensation and are devoid of alkyltin-based catalysts; novel organopolysiloxane polycondensation catalysts are useful therefor.

Abstract: The present invention relates to an organopolysiloxane composition that can be vulcanized at room temperature into an elastomer that is crosslinked by polycondensation and that does not contain alkyltin-based catalysts which exhibit toxicity problems. The invention also relates to novel polycondensation catalysts having a guanidine structure, in silicone chemistry, and to the uses thereof as catalysts for the organopolysiloxane polycondensation reaction.

Abstract: The present relates to novel organopolysiloxane compositions intended to generate an elastomer foam (or silicone foam) with good mechanical properties and low density low density, i.e. less than 0.35 g/cm3 and preferably less than 0.25 g/cm3.

Abstract: A curable composition apportioned between at least one Part A and at least one Part B, the Parts sealed within barrier means preventing contamination, the at least one Part A comprising: (i) one or more alkenyl-group containing prepolymers having at least one alkenyl group or moiety per molecule, and the at least one Part B comprising: (ii) one or more SiH-containing prepolymers having at least one Si—H unit per molecule; the composition additionally comprising: (iii) a catalyst for curing by addition of alkenyl-containing prepolymer (i) to SiH-containing prepolymer (ii), wherein prepolymer (ii) is substantially absent from Part A and prepolymer (i) is substantially absent from Part B, methods for preparing the composition, methods for sterilisation thereof, medical and non-medical use thereof, a device incorporating the composition, and a precursor therefor including its sterilisable precursor composition, in particular a terminally sterilisable or terminally sterile composition for medical use, particularly

Abstract: Single-component silicone elastomer compositions (SEA) are crosslinkable by polyaddition into self-adhesive state, contain at least one polyorganosiloxane (POS) including sites of ethylenic and/or acetylenic unsaturation {POS containing units ?Si— [unsaturation]}; at least one polyorganosiloxane (POS) containing units ?Si—H; a catalytic system including at least one metal catalyst and at least one crosslinking inhibitor; a filler; at least one adhesion promoter; optionally, at least one POS resin; optionally, at least one thermal resistance agent; and, optionally, at least one other functional additive, and are useful for gluing, assembling, sealing, e.g., joints, coatings, electrical, electronic and automobile engineering parts.